Aquestive Therapeutics, Inc. AQST Change in receivables
Change in receivables at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s change in receivables.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s change in receivables?
- Aquestive Therapeutics, Inc. (AQST) reported change in receivables of -$10.9M in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s change in receivables changed year-over-year?
- Aquestive Therapeutics, Inc.'s change in receivables decreased by 448.2% year-over-year, from $3.13M to -$10.9M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s change in receivables?
- Over 2 years (2022 to 2025), Aquestive Therapeutics, Inc.'s change in receivables has grown at a 19.1% compound annual growth rate (CAGR), from -$7.35M to $10.44M.
- What does change in receivables mean?
- Change in total receivables including trade and non-trade receivables.